PSIL-006

N/A

Report date: 2024/01/29 10:55:15
NME

Base Information

Drug NamePSIL-006
Drug Alias NamePSIL-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonistsSerotonin 6 (5-HT6) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPsilera Inc
China Registration ClassN/A

Develop Information

Active CompaniesPsilera Inc
Inactive CompaniesN/A
Active IndicationsFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A